ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Hold Natco Pharma; target of Rs 970: ICICI Direct
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 970 in its research report dated November 13, 2020.
Announcement as on 17 November 2020

Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug
​​ "Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules from the US Food and Drug Administration (USFDA)," Natco Pharma said in a regulatory filing.
Announcement as on 13 November 2020

Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug
Natco Pharma said its marketing partner Breckenridge Pharmaceutical received final approval from the USFDA for Pomalidomide Capsules, treatment of patients suffering from multiple myeloma cancer
Announcement as on 13 November 2020

Natco Pharma Q2 results: Net profit up 73% at Rs 204 crore
Consolidated total income of the company stood at Rs 827.9 crore for the quarter under consideration. It was Rs 518.9 crore for the same period a year ago.
Announcement as on 12 November 2020

Natco Pharma Q2 net profit rises 73% to Rs 204 crore on robust sales
Consolidated total income of the company stood at Rs 827.9 crore for the quarter under consideration
Announcement as on 12 November 2020

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 874.72
  • 12Day Average: 893.73
  • 20Day Average: 904
  • 50Day Average: 919.84
  • 100Day Average: 994.05
  • 150Day Average: 964.23
  • 200Day Average: 943.75

524816 Indicators & signals

Indicator MACD (12,26,9)

888.9, 905.99, -13.33
Indicator MACD is in negative zone

Indicator ADX (14)

8.21, 17.09, 20.15
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Wed Aug 2026 863.45 858.40 to 880.60 -0.35% 0.65 times
25 Tue Aug 2026 866.45 865.25 to 889.95 -1.92% 0.5 times
24 Mon Aug 2026 883.45 876.90 to 892.40 0.11% 0.82 times
21 Fri Aug 2026 882.50 877.95 to 900.00 0.54% 0.7 times
20 Thu Aug 2026 877.75 875.30 to 894.30 -1.05% 0.65 times
19 Wed Aug 2026 887.05 883.10 to 916.60 -1.2% 0.28 times
18 Tue Aug 2026 897.80 889.70 to 900.10 0.91% 0.35 times
17 Mon Aug 2026 889.70 870.70 to 898.85 -1.41% 1.15 times
14 Fri Aug 2026 902.40 885.75 to 962.25 -5.23% 3.53 times
13 Thu Aug 2026 952.25 917.60 to 960.40 4.07% 1.56 times
12 Wed Aug 2026 915.00 906.00 to 922.00 0.89% 0.46 times
11 Tue Aug 2026 906.90 903.55 to 929.40 -0.5% 0.73 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top